§ 13F · FUND PROFILE
Eversept Partners, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 107Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$1984.4T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | VERA | VERA THERAPEUTICS INC | 3.07M | $155.6T | 7.8% | NEW |
| 2 | QQQ | INVESCO QQQ TR | 225K | $138.2T | 7.0% | NEW |
| 3 | GSK | GSK PLC | 2.68M | $131.4T | 6.6% | NEW |
| 4 | UTHR | UNITED THERAPEUTICS CORP DEL | 253K | $123.1T | 6.2% | NEW |
| 5 | ABVX | ABIVAX SA | 658K | $88.7T | 4.5% | NEW |
| 6 | NTRA | NATERA INC | 334K | $76.6T | 3.9% | NEW |
| 7 | SNDX | SYNDAX PHARMACEUTICALS INC | 3.31M | $69.6T | 3.5% | NEW |
| 8 | VRDN | VIRIDIAN THERAPEUTICS INC | 1.78M | $55.5T | 2.8% | NEW |
| 9 | PCVX | VAXCYTE INC | 1.20M | $55.3T | 2.8% | NEW |
| 10 | TVTX | TRAVERE THERAPEUTICS INC | 1.17M | $44.9T | 2.3% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE EVERSEPT SIGNAL
AC read
Eversept Partners, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed